LMR Partners’s Inhibrx, Inc. Common Stock INBX Stock Holding History

LMR Partners’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-9,458	Closed	-$331K	–	1405
2024 Q1	$331K	Sell	9,458 -5,000	-35%	-$182K	﹤0.01%	809
2023 Q4	$549K	Hold	14,458	–	–	0.01%	637
2023 Q3	$265K	Hold	14,458	–	–	﹤0.01%	616
2023 Q2	$375K	Hold	14,458	–	–	﹤0.01%	525
2023 Q1	$273K	Hold	14,458	–	–	﹤0.01%	811
2022 Q4	$356K	Hold	14,458	–	–	0.01%	926
2022 Q3	$260K	Hold	14,458	–	–	﹤0.01%	977
2022 Q2	$164K	Buy	+14,458	New	+$213K	﹤0.01%	1078
2022 Q1	–	Sell	-25,000	Closed	-$1.09M	–	1443
2021 Q4	$1.09M	Buy	+25,000	New	+$1,000K	0.01%	667

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

LMR Partners's INBX Position: Q2 2024 in Review

LMR Partners sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 9,458 shares — an estimated $331K sold.

LMR Partners first reported a position in INBX in Q4 2021 and held it in 9 quarters. The position peaked at $1.09M in Q4 2021. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

LMR Partners reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
LMR Partners sold 9,458 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $331K.
LMR Partners first reported a position in Inhibrx, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
LMR Partners's Inhibrx, Inc. Common Stock position peaked at $1.09M in Q4 2021.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on LMR Partners's 13F filing for Q2 2024, filed 14 Aug 2024.